The increased inflammatory response has been identified as a major cause of morbidity and mortality in patients with COVID-19, and elevated concentration of pro-inflammatory markers such as cytokines IL-6, IL-18, and inflammatory chemokines IL-8, IP10 have been associated with a more severe disease outcome (Hojyo et al., 2020; Buicu et al., 2021; Satis et al., 2021; Guo et al., 2022). The gene discussed is IL6; the disease is COVID-19.